These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14602918)

  • 41. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.
    Yoshida Y; Izumi H; Torigoe T; Ishiguchi H; Yoshida T; Itoh H; Kohno K
    Oncogene; 2004 May; 23(25):4371-9. PubMed ID: 15064727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of p53 with the human Rad51 protein.
    Buchhop S; Gibson MK; Wang XW; Wagner P; Stürzbecher HW; Harris CC
    Nucleic Acids Res; 1997 Oct; 25(19):3868-74. PubMed ID: 9380510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 in recombination and repair.
    Gatz SA; Wiesmüller L
    Cell Death Differ; 2006 Jun; 13(6):1003-16. PubMed ID: 16543940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sliding of p53 along DNA can be modulated by its oligomeric state and by cross-talks between its constituent domains.
    Khazanov N; Levy Y
    J Mol Biol; 2011 Apr; 408(2):335-55. PubMed ID: 21338609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA binding induces conformational transition within human DNA topoisomerase I in solution.
    Oleinikov V; Sukhanova A; Mochalov K; Ustinova O; Kudelina I; Bronstein I; Nabiev I
    Biopolymers; 2002; 67(6):369-75. PubMed ID: 12209444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells.
    Wu CC; Huang KF; Yang TY; Li YL; Wen CL; Hsu SL; Chen TH
    PLoS One; 2015; 10(7):e0132052. PubMed ID: 26147394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.
    Das A; Mandal C; Dasgupta A; Sengupta T; Majumder HK
    Nucleic Acids Res; 2002 Feb; 30(3):794-802. PubMed ID: 11809893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Papillomavirus E2 protein interacts with and stimulates human topoisomerase I.
    Clower RV; Hu Y; Melendy T
    Virology; 2006 Apr; 348(1):13-8. PubMed ID: 16537084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequence-specific interaction of a conformational domain of p53 with DNA.
    Srinivasan R; Roth JA; Maxwell SA
    Cancer Res; 1993 Nov; 53(22):5361-4. PubMed ID: 8221671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Optimization of the expression of human DNA topoisomerase I in Pichia pastoris].
    Yang GW; Yuan BH; Ho KP; Dai X; Lin YC; Zhou SN
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):181-6. PubMed ID: 15969105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
    Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
    Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair.
    Subramanian D; Rosenstein BS; Muller MT
    Cancer Res; 1998 Mar; 58(5):976-84. PubMed ID: 9500459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 8-Oxoguanine rearranges the active site of human topoisomerase I.
    Lesher DT; Pommier Y; Stewart L; Redinbo MR
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12102-7. PubMed ID: 12209008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality.
    Woo MH; Losasso C; Guo H; Pattarello L; Benedetti P; Bjornsti MA
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13767-72. PubMed ID: 14585933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.
    Weger S; Hammer E; Heilbronn R
    FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type IA topoisomerase inhibition by clamp closure.
    Leelaram MN; Bhat AG; Godbole AA; Bhat RS; Manjunath R; Nagaraja V
    FASEB J; 2013 Aug; 27(8):3030-8. PubMed ID: 23612788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular processing determinants for the activation of damage signals in response to topoisomerase I-linked DNA breakage.
    Huang TH; Chen HC; Chou SM; Yang YC; Fan JR; Li TK
    Cell Res; 2010 Sep; 20(9):1060-75. PubMed ID: 20603643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs.
    Pilch DS; Yu C; Makhey D; LaVoie EJ; Srinivasan AR; Olson WK; Sauers RR; Breslauer KJ; Geacintov NE; Liu LF
    Biochemistry; 1997 Oct; 36(41):12542-53. PubMed ID: 9376359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NAD+ modulates p53 DNA binding specificity and function.
    McLure KG; Takagi M; Kastan MB
    Mol Cell Biol; 2004 Nov; 24(22):9958-67. PubMed ID: 15509798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reconstitution of enzymatic activity by the association of the cap and catalytic domains of human topoisomerase I.
    Yang Z; Champoux JJ
    J Biol Chem; 2002 Aug; 277(34):30815-23. PubMed ID: 12077150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.